Equities

Beijing Luzhu Biotechnology Co Ltd

Beijing Luzhu Biotechnology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)19.94
  • Today's Change0.36 / 1.84%
  • Shares traded1.20k
  • 1 Year change-40.39%
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024 04:51 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Beijing Luzhu Biotechnology Co Ltd is a China-based company principally engaged in drug discovery, research and development and commercialization. The Company is also engaged in out-licensing human vaccines and therapeutic biologics. Its products under clinical development include recombinant herpes zoster vaccine LZ901, and antibody injection products K3 and K193. Its LZ901 is mainly used to prevent herpes zoster caused by varicella zoster virus in adults aged 50 and above. The Company operates in the domestic market and overseas markets.

  • Revenue in HKD (TTM)0.00
  • Net income in HKD-269.54m
  • Incorporated2001
  • Employees133.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Laekna Inc0.00-398.67m2.63bn89.00--3.03-----3.30-3.300.002.23------0.00-------------------5.280.0655------52.81------
HighTide Therapeutics Inc0.00-1.02bn2.63bn66.00--3.18-----2.15-2.150.001.61------0.00--------------------0.0229-------393.76------
Golden Throat Holdings Group Co Ltd1.04bn270.42m2.73bn869.0010.091.638.732.630.36580.36581.412.270.41814.821.851,195,871.0010.8811.0015.8515.6372.5772.7926.0224.672.4834.740.2183.15-3.096.73-11.0419.61-32.1338.94
China Isotope & Radiation Corp7.17bn401.00m3.42bn3.11k8.520.67343.150.47631.251.2522.4215.860.53124.221.842,309,879.006.216.5712.8213.2652.4859.8911.7012.621.73--0.191928.277.8215.35-5.432.883.632.92
CK Life Sciences Intl (Holdings) Inc5.32bn17.25m3.51bn1.93k203.910.837430.940.65910.00180.00180.55380.43590.47282.964.742,755,038.000.15321.110.2111.4330.7630.520.32412.420.85120.87960.586159.000.89360.3407-86.93-42.010.2784--
Biocytogen Pharmaceuticals Beijng Co Ltd774.95m-413.96m3.55bn1.07k--4.18--4.58-1.04-1.041.952.130.273216.215.74726,974.30-14.59---18.88--70.59---53.42--1.24-21.300.4077--34.28--36.38------
CARsgen Therapeutics Holdings Ltd0.00-808.34m3.95bn516.00--2.03-----1.45-1.450.003.380.00----0.00-29.79---32.14----------9.54--0.0452------16.19------
Beijing Luzhu Biotechnology Co Ltd0.00-269.54m4.05bn133.00--3.67-----1.35-1.350.005.45------0.00----------------6.41--0.0185------65.62------
Jiangsu Recbio Technology Co Ltd0.00-618.26m4.05bn472.00--3.47-----1.29-1.290.002.420.00----0.00-25.47---30.68----------2.33--0.378------20.86------
Shandong Boan Biotechnology Co Ltd668.17m-129.04m4.65bn813.00--3.26--6.97-0.2534-0.25341.312.800.27321.352.53821,862.10-5.28---7.02--66.16---19.31--0.8383-7.470.2491--19.80--64.02------
Ocumension Therapeutics266.31m-410.54m4.70bn444.00--1.48--17.66-0.6327-0.63270.41024.570.0783.612.12599,804.80-12.03-38.78-13.21-41.4758.6062.30-154.16-975.823.72--0.0451--54.99--5.68--319.66--
Sihuan Pharmaceutical Holdings Group Ltd2.01bn-58.39m5.04bn2.87k--1.05--2.51-0.0063-0.00630.21630.51350.15720.81014.72700,268.70-2.18-6.85-3.34-9.1069.6475.81-13.85-36.231.35-2.630.1863---14.70-8.6097.23--0.9325--
Ascentage Pharma Group International239.96m-1.00bn5.17bn583.00--79.09--21.53-3.53-3.530.850.2250.08332.382.22411,588.80-34.73-44.93-52.82-57.0486.2487.68-417.02-976.101.42-15.030.9622--5.85100.76-4.84--2.82--
Microport NeuroTech Ltd-100.00bn-100.00bn5.31bn571.00------------------------------------------------21.61--768.73------
Consun Pharmaceutical Group Ltd2.80bn848.05m5.45bn3.13k6.281.385.831.951.061.063.504.830.49812.0810.05895,367.9015.1312.0422.5719.2574.1974.5530.3724.892.62--0.115540.8410.717.0314.8811.01-22.9318.43
ImmuneOnco Biopharmaceuticls Shanghi Inc-100.00bn-100.00bn5.49bn145.00-------------------------------------------------28.25--5.82------
Data as of Jun 07 2024. Currency figures normalised to Beijing Luzhu Biotechnology Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.